Prot# 13G01: A Phase 1 Dose Escalation Study of Repeat Intra-Articular Administration of tgAAC94, A Recombinant Adeno-Associated Vector Containing the TNFR:Fc Fusion Gene, in Inflammatory Arthritis Subjects With and Without Concurrent TNF-alpha Antagonist